Fitzgerald - Dermatology Flashcards

(57 cards)

1
Q

Derm assessment questions

A

Is the patient otherwise well? = localized skin infection (acne, rosacea, kp, seborrheic derm)

Is patient miserable but not systemically ill? = uncomfortable with itch, burning, pain (severe psoriasis, Norwegian scabies, herpes zoster)

Is patient systemically ill? = Systemic disease (varicella, transepidermal necrosis, SJS/erythema multiforme, Lyme disease)

Are there primary/secondary lesions? = Where is the oldest lesion and when did it occur? Where is the newest lesion and when did it occur?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Primary Lesions vs Secondary

A

PRIMARY

Result from disease process. No alteration from outside manipulation/tx/natural course of disease. Eg. vesicle

SECONDARY

Lesions altered by outside manipulation/tx/course of disease. Eg. crust

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Auspitz sign

A

Psoriasis

Pinpoint bleeding when scale is scraped off.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Vitiligo

A

Autoimmune against melanocytes

Common w/ other autoimmune diseases (thyroid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Palpable Purpura

A

NEVER BENIGN

“blueberry muffin” appearance

e.g. Meninigitis rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Macule

A

flat, nonpalpable discoloration

e.g.

Freckle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Papule

A

Solid elevation

e.g.

raised nevus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Umbilicated and example

A

Papule with indented center

e.g.

Molluscum contagiosum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pustule

A

Vesicle-like lesion with purulent content

e.g.

Impetigo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Patch and example

A

> 1 cm

flat, nonpalpable discoloration

e.g.

Vitiligo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Plaque

A

> 1 cm

Raised lesion, same or different color of surrounding skin, can result from coalescence of papules

e.g.

Psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bulla

A

> 1 cm

Fluid filled (bigger than vesicle)

e.g.

Necrotizing fasciitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cyst

A

Any size

Raised, enxapsulated, fluid-filled lesion

Always benign

e.g.

Intradermal cyst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Wheal

A

Any sized

Circumscribed area of skin edema

e.g.

Hives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Purpura

A

Purpura > 1 cm

Petechiae

Flat red-purple discoloration caused by RBCs lodged in the skin

Do NOT blanch

(vascular lesion = blanches)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Excoriation

A

Linear, raised, often covered with crust.

e.g.

scratch marks over pruritic areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Crust

A

Raised lesions produced by dried serum and blood remnants

e.g.

scab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lichenification

A

Skin thickening usually found over pruritic or friction areas

e.g.

Callus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Scales

A

Raised superficial lesiosn that flake with ease

e.g.

Dandruff

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Erosion

A

Loss of epidermis

e.g.

area under vesicle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Ulcer

A

Loss of epidermis AND dermis

e.g

arterial ulcer

Chancre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Fissure

A

Narrow linear crack into epidermis, exposing dermis

e.g.

athletes foot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Annular lesion

A

In a RING

e.g.

Erythema migrans (“bull’s eye”) in Lyme disease

24
Q

Scattered lesion

A

Generalized over body w/o specific pattern or distribution

e.g.

maculopapular rash in rubella

25
Confluent/coalescent lesions
Multiple lesions bleding together
26
Clustered lesions
Occurring ina group with pattern e.g. Acne-form drug induced rash seen with lithium, phenytoin, and iodine use = anticipated adverse effect
27
Linear lesions
In streaks e.g. Contact dermatitis poison ivy
28
Reticular lesions
Appearing in a net-like cluster e.g. Erythema infectiosum (Fifth Disease/slapped cheek)
29
Dermatomal or zosteriform lesion
Limited to boundaries of a single or multiple dermatomes e.g. Shingles NOTE: If suspected, start on high-dose acyclovir and come back in 24 hours to confirm dx Pain occurs 1-2 days before lesions erupt Suspect in acute shoulder/back pain, skin is "sore" Skin could also itch severely
30
Varicella
Infants vulnerable - vaccine is given at year 2-3 mm vesicles that start on trunk, appear on limbs 2-3 days later Nonclustered lesions at a variety of stages Mild to moderately ill Miserably itchy, risk for bacterial suprainfection of lesions **Tx:** Acyclovir within 24-48 hours of eruption **Prevention:** Varicella vaccine = 80% lifetime immunity first dose, 99% lifetime immunity second dose
31
Zoster (shingles)
Typically 50 years or older Possible in anyone with history of varicella Vesicles in a unilateral dermatomal pattern, slowly resolving with crusting Usually not systemically ill but quite miserable with pain and itch. Complications include postherpetic neuralgia, ophthalmologic involvement, and superimposed bacterial infection. **Tx:** High-dose acyclovir within 72 hours of eruption helps minimize duration and severity of illness **Prevention:** Zoster vaccine
32
Actinic Keratoses (AK)
Predominantly on sun-exposed skin Size ranges On skin surface - red, brown, scaly, often tender but usually minimally symptomatic Occassional flesh-colored - more easily felt than seen **Most common precancerous lesion though possibly represent early-stage SCC** **1 in 100 will progress to SCC** Tx: Topical 5-FU, 5% imiquimod cream, topical diclofenac gel or photodynamic therapy with topical delta-aminolevulinic acid Cryosurgery w/ liquid nitrogen, laser resurfacing, chemical peel
33
Basal cell carcinoma
More common than SCC Sun-exposed area Arises de novo (of new) Papule, nodule w/ or w/o central erosion Pearly or waxy appearance, usually relatively distinct borders w/ or w/o telengiectasia Metastatic risk low
34
Squamous cell carcinoma
Less common than BCC Sun-exposed areas Can arise from AK or de novo Red, conical hard lesions w/ or w/o ulceration Less distinct borders Metastatic risk greater (3-7%) Greatest metastatic risk = lesion on lip, oral cavity, genitalia
35
ABCDE Malignant Melanoma
A - Asymmetric B - Irregular borders C - Color not uniform D - Diameter usually 6mm or \> E - Evolving (new) lesion or change in a longstanding lesion, particularly in a nevus or other pigmented lesion E - Elevated (not consistently present) \* Majority of melanoma are de novo
36
Psoriasis vulgaris tx
medium-potency topical corticosteroid
37
Rosacea tx
Topical metronidazole
38
Pityriasis rosea
Acute, self-limited, erythematous skin disease Most likely viral Herald patch X-mas tree pattern Prodrome might occur but typically asymptomatic aside from itching Most cases do not require tx, may use medium-potency topical corticosteroid for itching Acyclovir may be useful in severe disease in shortening length of disease
39
Acanthosis nigricans
cutaneous manifestation of hyperinsulinemia puberty = worsenign insulin resistance can regress w/ control of disease e.g. after gastric bypass
40
Erysipelas
Infection of upper dermis, superficial lymphatics Streptococcus pyogenes (aka GABHS)
41
Cellulitis
Infection of dermis and subcutaneous fat Streptococcus pyogenes, less commonly MSSA beta-lactamase producing, MRSA (resistance via altered protein-binding sites)
42
Cutaneous abscess, furuncle
Skin infection involving hair follicle and surrounding tissue Carbuncles = cluster of furuncles connected subcutaneously, causing deeper suppuration and scarring Staph aureus (MSSA, MRSA)
43
Nonpurulent skin infection
**Necrotizing infection/Cellulitis/Erysipelas** Moderate = inpatient for IV PCN or Ceftriaxone, Cefazolin, or Clindamycin Mild = Oral Rx of PCN VK or Cephalosporin or Dicloxacillin or Clindamycin Dicloxacillin = PCN stable in beta-lactamase Clindamycin = most common abx assoc. w/ c-diff; take with probiotic
44
Purulent skin infection
**Furuncle/Carbuncle/Abscess** Mild = I & D Moderate = I & D and C & S Empiric therapy with Bactrim, Doxy Defined Rx MRSA = Bactrim MSSA = Dicloxacillin or Cephalexin \*Keflex = First gen $4
45
Brown Recluse Spider Bite
"Red, white, and blue" Central blistering with surrounding gray to purple discoloration at bite site Surrounded by ring of blanched skin surrounded by large area of redness
46
Most common cause of new onset ulcerating skin lesion across North America
MRSA
47
Nafcillin
Narrow spectrum Beta-lactamase resistant PCN Use of not risk factors for MRSA
48
Rocky mountain spotted fever s/sx and dx
Tick-borne Most cases occur in spring or early summer Early in disease: fever, malaise, arthralgias, headache, nausea w/ or w/o vomiting; children might present w/ abd pain Rash between day 3 and 5 of illness Early disease = empiric tx based on clinical judgment and epidemiological likelihood Later disease = dx via skin bx or serological testing
49
Rocky mountain spotted fever Tx
Start within 5 days of symptom onset Doxycycline 200 mg/day in two divided doses Tx should continue until 3 days of patient being afebrile Doxy: risk of _dental staining_ in children Doxy typically tolerated well except for _N&V_, give antiemetics/antimotility agents as needed Doxy assoc. w/ _photosensitivity_ = counsel about skin protection Pregnancy: use chloramphenicol if available
50
Lyme disease
Erythema migrans (central erythema, ring remains flat, blanches, does not desquamate) **Tx:** Doxy 100 mg BID x 10-21 days Amox 500 mg every 6-8 hours for 21 to 30 days Cefuroxime 500 mg BID x 20 days Use Amox/Ceftin for children **Prophylaxis:** Within 72 hours of tick removal: Doxy 200 mg x 1 dose
51
CA-MRSA tx
Bactrim DS = 2 tablets x 5-10 days Rifampin can be added - use w/ caution CYP450 inducer If can't have sulfa (bactrim), use: Doxy Minocycline To cover staph and strep use Bactrim with a beta-lactam (cephalosporin)
52
Babies
Avoid sun exposure Lightweight long pants, long-sleeved shirts, brimmed hats May apply sunscreen 15 spf or \> minimal amt If sunburned - apply cold compresses to affected area
53
Sun safety Children \> 6 months and adults
Hat w/ 3 inch brim or bill facing forward Sunglasses that block 99 to 100% of UV, cotton clothing w/ tight weave Stay in shade limit sun exposure during peak intensity hours 10 and 4 Use SPF 15 or \> on both sunny and cloudy days Protect against UVB and UVA rays Apply enough sunscreen 1 oz (30 mL) per sitting for older child and adult Reapply every 2 hours or after swimming/sweating Extra caution near water, sand, snow (reflects UV rays)
54
Topical medication ## Footnote amount: for hands, face, anogential region one arm, anterior or posterior trunk one leg entire body
2 g 3 g 6 g 30-60 g
55
Topical medication Absorption Which parts of the body have the greatest absorption? What parts of the body have the least absorption Relationship between medication viscosity and absorption?
face, axillae, genitals palms and hands and soles of the feet cutaneous absorption is inversely proportion to the thickness of the stratum corneum Thicker/more viscous = greater absorption
56
Topical Corticosteroids ## Footnote Uses potency determined by? techniques to enhance delivery/potency? Examples of low potency (class 5-7) midrange potency (3-4) high potency (2) super-high potency (1)
inflammatory and allergy derm disorders potency is based on vasoconstrictive effects techniques to enhance delivery/potency? cover with an occlusive dressing. low potency (class 5-7): * hydrocortizone (all strengths and types) * triamcinolone * fluocinolone 0.01%; 0.025% midrange potency (3-4) * betamethasone * mometasone high potency (2) * fluocinolone 0.2% * fluocinonide 0.05% * betamethasone 0.05% super-high potency (1) * Clobetasol * halobetasol
57
Antihistamines ## Footnote MOA? Symptoms controlled? Compare 1st and 2nd generation antihistamines Examples of 1st gen Examples of 2nd gen
**MOA:** Blocking histamine-1 receptor site (antagonist) in the respiratory tract, blood vessels & GI smooth muscle **Symptoms controlled:** itching and allergy (runny nose) also antiemetic. **SE:** anticholinergic and sedation (mainly 1st gen) **Compare 1st & 2nd gen antihistamines:** 1st gen crosses the blood-brain barrier - more sedation and cognitive effects. **Examples of 1st gen** * diphenhydramine -- Benedryl * chlorpheniramine -- Chlortrimetron (cranky cousin) **Examples of 2nd gen** * loratadine -- Claritin * desloratadine -- Clarinex * cetirizine -- Zyrtec * fexofenadine. -- Allegra * levocetirizine -- Xyzal